Company Moogene Medi Co., Ltd.

Equities

A322970

KR7322970005

Biotechnology & Medical Research

End-of-day quote Korea S.E. 06:00:00 2024-06-19 pm EDT 5-day change 1st Jan Change
1,900 KRW +1.12% Intraday chart for Moogene Medi Co., Ltd. -6.40% -31.28%

Business Summary

Moogene medi Co Ltd is a Korea-based company mainly engaged in the research and development of biological and chemical agents capable of treating incurable diseases. The Company mainly manufactures and sells medicines such as treatments of colorectal cancer, treatments for hair loss, and treatments for diabetes.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Nanomaterials Based on Chemical Technologies
100.0 %
20 100.0 % 140 100.0 % +600.19%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
20 100.0 % 140 100.0 % +600.19%

Managers

Managers TitleAgeSince
Chief Executive Officer 50 -
Director/Board Member 48 -
Director/Board Member 56 -
Comptroller/Controller/Auditor 43 -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 50 -
Director/Board Member 56 -
Director/Board Member 48 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 10,051,978 4,748,139 ( 47.24 %) 0 47.24 %

Company contact information

Moogene Medi Co., Ltd.

10th floor Utech Valley C-dong 25 Misagangbyeonjungang-ro

12939, Hanam-si

+

http://www.moogene.com
address Moogene Medi Co., Ltd.(A322970)
  1. Stock Market
  2. Equities
  3. A322970 Stock
  4. Company Moogene Medi Co., Ltd.